Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05380349
EARLY_PHASE1

Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma

Sponsor: Swedish Medical Center

View on ClinicalTrials.gov

Summary

Proposed treatment of subjects with newly diagnosed glioblastoma with novel personalized drug regimens identified to be effective in vitro using cancer stem cells derived from their individual tumors, alongside standard of care radiation and TMZ.

Official title: A Phase 1 Study of Combination Drug Therapy Based on Personalized Cancer Stem Cell (CSC) High-Throughput Drug Screening (HTS) With Standard of Care for Newly Diagnosed Glioblastoma

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2024-04-19

Completion Date

2027-12

Last Updated

2025-05-16

Healthy Volunteers

No

Interventions

DRUG

combinations of up to 3 FDA approved drugs from a panel of compounds

personalized drug combinations

Locations (1)

Swedish Medical Center

Seattle, Washington, United States